Director Value Access and Policy Germany

Position Summary

The Director, Access and Policy, Germany, is a key partner on Acadia’s European Value, Access and Policy team, and has accountability to achieve and maintain appropriate pricing and market access through propositions that deliver value to patients, healthcare systems, society and the company. Together with the Germany management team and the European Value, Access and Policy team, this role will define Acadia’s approach to Market Access in the Germany and help build an organization that can execute it cross-functionally. The Director will also shape the product access strategies and ensure that local needs (e.g., additional evidence) are flagged and communicated.

Primary Responsibilities

• Primary geographical responsibility is Germany, and additional markets may come under the accountability of the role, depending on experience, workload and organizational need as we expand the business footprint across the European continent
• Ensure Germany Pricing and Access launch strategies are of high quality and are fit-for-purpose
• Develop pricing & access strategy incorporating additional evidence needs, value proposition beyond the drug, managed entry schemes and other agreements to ensure mutual value, and pricing strategy
• Ensure high quality and timely delivery of the Germany P&R dossier
• In collaboration with local and European teams, identify evidence requirements for successful access in Germany and support the creation of program-specific Evidence Plans
• Ensure a coordinated negotiation strategy with a clearly defined approach
• Develop appropriate broad stakeholder relationships to support access engagement and education – including appropriate consultation of patients regarding their needs and the impact of the disease in their local context
• Establish and maintain personal relationships with select payers, advisors, key opinion leaders and other stakeholders
• Prepare and manage annual strategic plans and budgets for the function with accurate forecasting and prudent decision making
• Monitor trends and anticipate key developments in Germany with respect to Health Technology Assessment and Government/Payer reimbursement initiatives.
• Other responsibilities as assigned

Education/Experience/Skills

• Bachelor’s degree in a life science or related field required, MBA or PhD preferred. A combination of relevant education and applicable experience may be considered.
• Targeting 10 years of progressively increasing responsibilities, with 5 years’ leadership experience in Market Access within a pharmaceutical/biotech organization and significant scientific exposure within rare disease, ideally in the CNS realm, and in the context of early patient access programs
• Recent experience in early patient access programs and launch of orphan drugs ideally with direct or adjacent experience within the CNS space
• Hands-on experience in pricing negotiations in Germany
• Experience and proven success in cross-functional teamwork
• Ability to collaborate cross-functionally with commercial, medical, clinical and regulatory colleagues to foster a culture of collaboration and innovation
• Strong computer skills, excellent written and oral communication skills, including strong formal presentation skills
• Local and international travel is required up to 30% of the time

Scope

Having wide-ranging experience, uses professional concepts and company objectives to identify and resolve complex issues in creative and effective ways, exercising judgment in selecting methods, techniques, and evaluation criteria for obtaining results.  Establishes strategic plans for designated function(s).  Develops methods, techniques, and evaluation criteria for projects, programs, and people.  Works on complex issues where analysis of situations or data requires an in-depth evaluation of variable factors.  Determines methods and procedures on new assignments and may coordinate activities of other personnel.

#LI-HYBRID